Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a ...

Electrochemical devices like batteries and fuel cells help power our modern lives. These devices traditionally contain a ...

A newly engineered niobium battery material enables record-fast charging by optimizing lithium-ion movement at the atomic ...

In recent years, researchers have been trying to develop increasingly advanced battery technologies that can be charged ...

Ionis Pharmaceuticals IONS announced that the European Commission (“EC”) has approved Wainzua (eplontersen) for treating ...

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...

Lithium-6 is a crucial material for nuclear fusion reactors, but isolating it is challenging – now researchers have found a ...

Researchers injected CO2 gas into seawater while applying an electrical current. The process transformed dissolved ions, minerals in seawater into clusters of solid particles. The clusters hold over ...

William Blair analyst Myles Minter reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares opened ...